In addition to smoking and blood pressure, cholesterol is a major controllable risk factor for coronary heart disease and stroke. Heart disease is the number one cause of death in the United States. More than seventy-one million American adults have high cholesterol. September is observed every year as the National Month of Cholesterol Education. The Government and healthcare providers utilize the opportunity to raise awareness about the risks of high cholesterol, campaign for better detection, treat those at risk, and support health professional training.
About Cholesterol Screening
The National Cholesterol Education Program provides evidence-based resources and recommendations to healthcare providers, and new guidelines for cholesterol are in development. The program recommends that adults aged 20 years or older have their cholesterol checked every 5 years.
Because high cholesterol does not have symptoms, many people do not know that their cholesterol is too high. A simple blood test is all that is needed to check cholesterol level or lipids. People with total cholesterol of 200 mg/dl or higher need to get screening done more often. It is important to know both good and bad cholesterol numbers. Good cholesterol of around 60 mg/dL or more protects against heart disease. Bad cholesterol should be lower than 100 mg/dL. Dietary changes can help lower blood cholesterol.
Statistics show that though the number of people who reported that they underwent cholesterol screening within the previous 5 years increased from 73% to 76% during 2005-2009, only a few states have met the 82% Healthy People 2020 objective, and disparities in getting screened continue.
Fast and Accurate Results with the Right Cholesterol Testing Device
Using the right device for lipid screening is crucial to accuracy. Cholestech LDX, an excellent point-of-care cholesterol screening system from Alere meets National Cholesterol Education Program (NCEP) guidelines. This affordable device provides results in just 5 minutes from a single drop of blood, allowing on-the-spot CHD risk assessment and care decisions. Studies have indicated that the device provides results that match up extremely well with standard laboratory tests. This easy-to-use system can measure cholesterol, lipid profile and glucose, ALT, AST, TC, TC/HDL, TC-HDL-GLU, and hs-CRP values.